Equity and Efficiency in Lung and Breast Cancer Screening

Lung and breast cancer screening are critical components of global cancer prevention, yet substantial disparities persist in access, uptake, and outcomes across populations and health systems. Differences by socioeconomic status, geography, gender, smoking behavior, insurance coverage, and risk profile continue to shape who benefits from screening and at what cost. While evidence supports the clinical effectiveness of low-dose CT for lung cancer and mammography for breast cancer, important questions remain regarding cost-effectiveness, optimal targeting of high-risk groups, including non-smokers and individuals with a family history, and equitable allocation of limited resources.This Research Topic aims to examine equity and efficiency in lung and breast cancer screening from a health economics and public health perspective. It focuses on how health behaviors, risk stratification, financing arrangements, and policy interventions influence screening participation, value for money, and distributional outcomes. By integrating economic evaluation, behavioral analysis, and policy assessment, the Research Topic seeks to generate evidence that supports more effective, sustainable, and equitable screening strategies across diverse global contexts.We welcome original research, reviews, and policy-oriented contributions addressing health economic aspects of lung and breast cancer screening at local, national, or global levels. Topics include, but are not limited to:• Cost-effectiveness and economic evaluations of lung and breast cancer screening strategies• Socioeconomic, demographic, behavioral, and genetic disparities in screening access, uptake, and outcomes• Behavioral economic analyses of screening decisions, risk communication, and shared decision-making• Development and assessment of risk prediction and stratification models for efficient screening• Comparative effectiveness of screening approaches across risk and demographic subgroups• Health financing mechanisms, insurance design, and private sector roles in screening access• Policy analysis of reimbursement, healthcare organization, and system-level determinants of screening efficiency and sustainability• Cross-country and global comparisons of screening policies and interventions Topic editors: Le Wang, Lingbin Du, Yuqing Hu Source: https://www.frontiersin.org/research-topics/78049/equity-and-efficiency-in-lung-and-breast-cancer-screening